Amyloid-beta
Assets acting on this target.
- Class
- Therapeutic active immunotherapy vaccine
- Notes
- hand ruling, audit finding #971; ACI-24.060 is an active vaccine; the stored target's parenthetical calls it a monoclonal antibody, which is the opposite modality; source: https://www.acimmune.com/pipeline/aci-24-060/
By indication
Related mechanisms
Amyloid-beta drugs compared
4 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| AV-1959R | Nuravax, Inc. | Biologic (active vaccine) | Phase 2 | Phase 2 in Alzheimer's Disease |
| UB-311 | Vaxxinity | vaccine | Phase 2 | Phase 2 in Early Alzheimer's Disease |
| ACI-24.060 | AC Immune | Biologic (liposomal active vaccine) | Phase 1/2 | Not recorded |
| ALZ-101 | Alzinova AB | Biologic (active vaccine) | Phase 1 | Phase 1 in Alzheimer's Disease |